North Carolina Attorney General Jeff Jackson and State Treasurer Brad Briner on Thursday announced the terms of a settlement with an EpiPen manufacturer that will bring the state millions.
Jackson said the company that sold the EpiPens, Mylan, participated in anti-competitive practices that allowed them to raise the price and overcharge for their product. A settlement will mean a refund for some in our state.
Other WRAL Top Stories
"From 2007 to 2016, the price of this went from about $100 to about $600, a 6X increase in under a decade," Jackson said while holding an EpiPen.
The terms of the settlement determine that the state will get $11 million with a big chunk of that going to taxpayers.
"We also negotiated a reduction in out-of-pocket costs for all families going forward," Jackson said. "This is a very important message to send to prescription drug manufacturers everywhere, that if we have good evidence that you've broken the law, we're going to hold you accountable."
"As someone who carries an EpiPen and someone who has a child who carries an EpiPen, this particularly hits close to home for me," Briner said.
$4.2 million of this settlement comes to the state health plan ... this money belongs to the people of North Carolina, it'll go right back to keeping premiums down."
This isn't the first instance of a lawsuit against Mylan in our state. In 2017, then-Attorney General Josh Stein announced the state would settle with Mylan for $21.4 million. The most recent lawsuit was launched after the previous class action suit was settled.
Mylan has since merged with Pfizer's Upjohn business in 2020 to form Viatris.